Glucose Effects on Skin Keratinocytes

Implications for Diabetes Skin Complications

  1. Natalia Spravchikov1,
  2. Galina Sizyakov1,
  3. Marina Gartsbein2,
  4. Domenico Accili3,
  5. Tamar Tennenbaum2 and
  6. Efrat Wertheimer1
  1. 1Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv
  2. 2Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel
  3. 3Columbia University/Berrie Research Pavilion, New York, New York

    Abstract

    Altered skin wound healing is a common cause of morbidity and mortality among diabetic patients. However, the molecular mechanisms whereby diabetes alters skin physiology have not been elucidated. In this study, we investigated the relative roles of hyperglycemia, insulin, and IGF-I, all of which are abnormal in diabetes, in primary murine skin keratinocytes. These cells proliferate and differentiate in vitro in a manner similar to skin in vivo. It was found that in the presence of high glucose (20 mmol/l), the glucose transport rate of primary proliferating or differentiating keratinocytes was downregulated, whereas at 2 mmol/l glucose, the transport rate was increased. These changes were associated with changes in the GLUT1 expression and with changes in the affinity constant (Km) of the transport. Exposure to high glucose was associated with changes in cellular morphology, as well as with decreased proliferation and enhancement of Ca2+-induced differentiation of keratinocytes. Furthermore, in the presence of high glucose, ligand-induced IGF-I receptor but not insulin receptor (IR) autophosphorylation was decreased. Consequently, in high glucose, the effects of IGF-I on glucose uptake and keratinocyte proliferation were inhibited. Interestingly, lack of IR expression in IR-null keratinocytes abolished insulin-induced glucose uptake and partially decreased insulin- and IGF-I–induced proliferation, demonstrating the direct involvement of the IR in these processes. Our results demonstrate that hyperglycemia and impaired insulin signaling might be directly involved in the development of chronic complications of diabetes by impairing glucose utilization of skin keratinocytes as well as skin proliferation and differentiation.

    Footnotes

    • Address correspondence and reprint requests to Dr. Efrat Wertheimer, Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel. E-mail: effy{at}patholog.tau.ac.il.

      Received for publication 3 March 2000 and accepted in revised form 20 March 2001.

      dGlc, 2-deoxy-[3H]glucose; IGFR, IGF-I receptor; IR, insulin receptor; KO, knockout; NIH, National Institutes of Health; PBS, phosphate-buffered saline; PKC, protein kinase C; WT, wild-type.

    « Previous | Next Article »Table of Contents